Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ .
Adverse events should also be reported to GE HealthCare at
gpv.drugsafety@gehealthcare.com
doses currently produced globally every year1
more iodinated contrast media doses to be delivered annually by 20251
accredited contrast media production facilities globally
invested over the last decade to increase capacity1
GE HealthCare has a distinguished heritage of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.
Beyond the scan
Securing future supply of contrast media.
Our +PLUS PAK packaging, used for contrast media product, is 100% recyclable. A life-cycle analysis showed that our polypropylene bottles, compared to glass, have a 59% lower environmental impact, and requires 45% less cumulative energy. Our +PLUS PAK bottles, also require less secondary packaging, helping reduce carbon footprint.2
1. GE Healthcare Data on File: Planned Investment 2023
2. Dhaliwal et al. Int J Life Cycle Assess 2014; 19: 1965-73.
cGMP: Current Good Manufacturing Practice
